glp-1 and autoimmune Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in diseases 💉 Ozempic for autoimmune? Spill

Conversely, the addition of a SGLT2i to GLP-1RA treatment showed only an increased incidence of genital infections

Li Y, Glotfelty EJ, Karlsson T, Fortuno LV, Harvey BK, Greig NH

Key factors influencing vomiting risk include: Dose escalation speed rapid increases in dose are associated with higher symptom rates Individual susceptibility some patients are inherently more prone to gastrointestinal side effects Concurrent medications other drugs affecting gastric motility may compound effects Dietary habits large, high-fat meals can exacerbate symptoms It is important to note that whilst mild, occasional vomiting can be an expected side effect, severe or persistent vomiting is not normal and may indicate complications requiring medical assessment

Xie, Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome